Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - Greece

Greece

The Diagnostic Imaging Devices market market in Greece is forecasted to achieve a revenue of US$190.10m by 2024.
This indicates a projected annual growth rate of 2.95% from 2024 to 2029, leading to a market volume of US$219.80m by 2029.
It is worth noting that in terms of global comparison, the United States is expected to generate the highest revenue, amounting to US$11,930.00m in 2024.
Greece's diagnostic imaging devices market is experiencing a surge in demand due to increasing investment in healthcare infrastructure and rising prevalence of chronic diseases.

Key regions: Germany, Japan, Netherlands, Spain, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Diagnostic Imaging Devices market in Greece has been experiencing steady growth in recent years, driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in Greece have been shifting towards advanced diagnostic imaging devices that offer higher image quality, faster scanning times, and improved patient comfort. This is in line with global trends, as healthcare providers and patients alike seek more accurate and efficient diagnostic tools. Additionally, there is a growing demand for portable and handheld imaging devices that can be used in remote areas or during emergencies. Trends in the market indicate a strong focus on technological advancements and innovation. Manufacturers are continuously developing new imaging modalities, such as 3D and 4D imaging, as well as improving existing technologies like magnetic resonance imaging (MRI) and computed tomography (CT) scanners. These advancements not only enhance the diagnostic capabilities but also reduce the overall cost and time required for imaging procedures. Local special circumstances in Greece also contribute to the development of the Diagnostic Imaging Devices market. The country has a well-established healthcare system with a high demand for medical imaging services. Additionally, Greece has a large aging population, which leads to an increased need for diagnostic imaging devices to detect and monitor age-related diseases. Furthermore, the government has been investing in the modernization of healthcare infrastructure, including the procurement of advanced imaging equipment. Underlying macroeconomic factors play a significant role in the growth of the Diagnostic Imaging Devices market in Greece. Despite the economic challenges faced by the country in recent years, healthcare remains a priority sector. The government has been investing in healthcare reforms and increasing healthcare expenditure, which includes the procurement of medical devices. Furthermore, Greece is a popular destination for medical tourism, attracting patients from neighboring countries for advanced diagnostic imaging procedures. In conclusion, the Diagnostic Imaging Devices market in Greece is developing due to customer preferences for advanced imaging technologies, market trends towards innovation, local special circumstances such as an aging population and healthcare infrastructure modernization, and underlying macroeconomic factors including government investments in healthcare and medical tourism. This growth is expected to continue as the demand for accurate and efficient diagnostic imaging devices remains high.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.